Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial.
Eur Urol
; 83(1): 82-89, 2023 Jan.
Article
in En
| MEDLINE
| ID: mdl-36216658
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Carcinoma, Transitional Cell
Type of study:
Clinical_trials
Limits:
Aged
/
Humans
Language:
En
Journal:
Eur Urol
Year:
2023
Document type:
Article
Affiliation country:
Italia
Country of publication:
Suiza